MiR-3168, miR-6125, and miR-4718 as potential predictors of cisplatin-induced nephrotoxicity in patients with head and neck cancer

Abstract Background No biomarker is available for identifying cancer patients at risk of developing nephrotoxicity when treated with cisplatin. Methods We performed microRNA (miRNA) sequencing using plasma collected 5 days after cisplatin treatment (D5) from twelve patients with head and neck cancer...

Full description

Bibliographic Details
Main Authors: Julia C. F. Quintanilha, Maria A. Cursino, Jessica B. Borges, Nadine G. Torso, Larissa B. Bastos, Juliana M. Oliveira, Thiago S. Cobaxo, Eder C. Pincinato, Mario H. Hirata, Murilo V. Geraldo, Carmen S. P. Lima, Patricia Moriel
Format: Article
Language:English
Published: BMC 2021-05-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-021-08317-2